I…have since been brought in to help BMR with better coverage of small-cap biotech stocks and bring back some credibility. you can expect a lot more stories from me on BMR in the future.
I would submit that the credibility of biomedreports is too far gone to be restored, at least as far as this board is concerned. Further, I would suggest that you do more DD about a company such as MNTA before penning an article in which you purport to know what you are talking about. Lovenox is not a biosimilar.